THE INVESTIGATIONAL DRUG PROGRAM
The BC Cancer Agency’s Investigational Drug Program (IDP) provides fee-for-service preclinical research services and contract manufacturing for academic and private-sector researchers. IDP’s mandate is to help its research partners develop promising therapeutic compounds to the point where they can be tested in early phase human clinical trials.
IDP works closely with its partners on the pre-clinical development and formulation of experimental compounds. The program’s facilities are fully GLP and GMP compliant and have successfully produced more than 130 distinct batches of injectable experimental drug formulations.
IDP has a core expertise in cancer therapeutics and working relationships with oncologists specializing in all types of cancer who can provide timely and cost-effective guidance for product development based on sound scientific investigation. Having the support of clinician specialists for drug development can significantly improve a researcher’s success in obtaining funding and approval for clinical trials.
A WEALTH OF EXPERIENCE AND EXPERTISE
IDP provides access to a wide range of exceptional capabilities in cGMP manufacturing of parenteral drugs (aseptic fill procedures), analytical services, in vivo pharmacology, cGLP safety pharmacology, clinical trials support. IDP has a core competency in the development of cancer-related therapeutics, pre-clinical animal models, as well as, nanoparticle formulations and drug delivery.
All aspects of the Investigational Drug Program are quality driven and are conducted in accordance with the best scientific practices, providing the utmost level of commitment to academic and industry (biotechnology / pharmaceutical) clients.
The Investigational Drug Program has the capability of delivering flexible, tailored approaches to preclinical research objectives, whether the requirements are for a single study service or a complete research program.
IDP’s partners include academic cancer researchers across North America and research teams from biotechnical and pharmaceutical companies operating around the world. IDP is open to all types of research collaborations and partnerships: academic, commercial; big or small. Contact Us.
ABOUT THE BC CANCER AGENCY
The BC Cancer Agency, an agency of the Provincial Health Services Authority (PHSA), provides comprehensive cancer control program for the people of British Columbia in partnership with regional health authorities. This includes prevention, screening and early detection programs, research and education, and care and treatment.